Literature DB >> 4984200

Yellow fever virus. II. Factors affecting the plaque neutralization test.

S L Spector, N M Tauraso.   

Abstract

In studies on the factors and conditions influencing the yellow fever (YF) virus plaque neutralization test, 60 min was found to be the minimal time necessary for equilibration of the virus-antibody complex at 23 and 37 C. Maximal virus titers in the diluent controls and the pre- and postinoculation serum-containing mixtures occurred by the 60-min adsorption time. Serum neutralization indices also seemed to level by this time. Heating (56 C for 30 min) decreased the neutralizing capacity of serum. However, the slope of the neutralization curve was not affected. The addition of native (unheated) "serum factor" in the form of fresh guinea pig or monkey sera partially restored the neutralizing activity lost by heating in some, but not all, sera. Many sera contained nonspecific inhibitors of YF virus infectivity and neutralization. Preliminary studies with ether extraction suggest that these inhibitors are lipid in nature.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4984200      PMCID: PMC378081          DOI: 10.1128/am.18.5.736-743.1969

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  10 in total

1.  Kinetic studies on the neutralization reaction between Japanese encephalitis virus and antiserum.

Authors:  N HASHIMOTO; A M PRINCE
Journal:  Virology       Date:  1963-03       Impact factor: 3.616

2.  Effects of medial temporal lesions on taste preference in the monkey.

Authors:  L WEISKRANTZ
Journal:  Nature       Date:  1960-09-03       Impact factor: 49.962

3.  A VIRUS IN CHICK EMBRYOS WHICH INDUCES RESISTANCE IN VITRO TO INFECTION WITH ROUS SARCOMA VIRUS.

Authors:  H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1960-08       Impact factor: 11.205

4.  Inactivation of Certain Neurotropic Viruses in Vitro by Serum Lipids.

Authors:  J Casals; P K Olitsky
Journal:  Science       Date:  1947-09-19       Impact factor: 47.728

5.  The dengue group of viruses and its family relationships.

Authors:  A B SABIN
Journal:  Bacteriol Rev       Date:  1950-09

6.  Yellow fever vaccine. I. Development of a vaccine seed free from contaminating avian leukosis viruses.

Authors:  N M Tauraso; S L Spector; W G Jahnes; A Shelokov
Journal:  Proc Soc Exp Biol Med       Date:  1968-04

7.  The neutralization of arboviruses. II. Neutralization in heterologous virus-serum mixtures with four group B arboviruses.

Authors:  E G Westaway
Journal:  Virology       Date:  1965-08       Impact factor: 3.616

8.  Studies on the neutralization of Japanese encephalitis virus. I. Application of kinetic neutralization to the measurement of the neutralizing potency of antiserum.

Authors:  Y Ozaki; K Tabeyi
Journal:  J Immunol       Date:  1967-06       Impact factor: 5.422

9.  Yellow fever virus. I. Development and evaluation of a plaque neutralization test.

Authors:  S Spector; N M Tauraso
Journal:  Appl Microbiol       Date:  1968-11

10.  Plaque formation and isolation of pure lines with poliomyelitis viruses.

Authors:  R DULBECCO; M VOGT
Journal:  J Exp Med       Date:  1954-02       Impact factor: 14.307

  10 in total
  4 in total

1.  Yellow fever vaccine. 3. Antibody response in monkeys inoculated with a vaccine free from contaminating avian leukosis viruses.

Authors:  N M Tauraso; S L Spector; R W Trimmer
Journal:  Arch Gesamte Virusforsch       Date:  1972

2.  Yellow fever vaccine. V. Antibody response in maonkeys inoculated with graded doses of the 17D vaccine.

Authors:  R A Mason; N M Tauraso; R K Ginn; T C O'Brien; R W Trimmer
Journal:  Appl Microbiol       Date:  1972-05

3.  Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization of West Nile virus.

Authors:  Erin Mehlhop; Steevenson Nelson; Christiane A Jost; Sergey Gorlatov; Syd Johnson; Daved H Fremont; Michael S Diamond; Theodore C Pierson
Journal:  Cell Host Microbe       Date:  2009-10-22       Impact factor: 21.023

Review 4.  Complement and its role in protection and pathogenesis of flavivirus infections.

Authors:  Panisadee Avirutnan; Erin Mehlhop; Michael S Diamond
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.